The episode will feature John Amos, Chief Executive Officer at VIVUS LLC, along with leading weight-loss experts, to discuss QSYMIA® (phentermine and topiramate extended-release capsules CIV ...

It’s also prescribed off-label for weight loss. But the combination of topiramate and phentermine, sold under the brand name Qsymia, is FDA-approved for weight management. Studies show ...